Product
TACROLIMUS
1 clinical trial
1 indication
Indication
Organ TransplantationClinical trial
Prospective, Multicenter, Randomized, Open-label, Parallel-group Controlled Phase 3 Study of Tacrolimus Minimization in Kidney Transplant Recipients Selected According to the AGORA Algorithm for Their Low Immunological Risk and Medium-term Graft FailureStatus: Not yet recruiting, Estimated PCD: 2026-08-10